Health Sciences PhD program, Universidad Católica de Murcia UCAM, 9 Campus de los Jerónimos n°135, 30107 Guadalupe, Murcia, Spain.
Lyposmol Biotech, Isabel Colbrand, 6, 28050, Madrid, Spain.
J Orthop Surg Res. 2020 Apr 9;15(1):137. doi: 10.1186/s13018-020-01664-z.
The infiltration of the stromal vascular fraction (SVF) of autologous adipose tissue to treat osteoarthritis has been used for several years demonstrating its safety and noticeable efficacy. This article presents clinical data from patients afftected by moderate and severe knee osteoarthritis demonstrating safety and clinical efficacy of the treatment when this autologous cell product is injected in the knee joint and patients evaluated post-operatively after 1 year. However, what do we know about the mechanism that underlies this clinical improvement? This article proposes, for the first time in our opinion, a hypothesis of the mode of action that involves structural and molecular interactions between SVF and infrapatellar fat pad (IFP). As consequence, there would be a re-education of intra-articular adipose tissue, which we consider a key player for the clinical effect observed in the mid and long term mainly due to immuno-regulatory mechanisms.
This is a retrospective and not controlled study that evaluated 50 patients (100 joints) ranging from 50 to 89 years old, separated by age cohorts. Clinical efficacy was assessed using the Lequesne, WOMAC, and VAS scales, by ultrasound control and quantification of the biochemical profiles of synovial fluid.
There were no serious adverse effects. All the indexes studied showed a significant clinical improvement after 1-year follow-up for all ages and OA degree groups. This finding was correlated with the ultrasound observations and biochemical data, which show a marked decrease in catabolic and pro-inflammatory molecules (MMP-2, IL-1B, IL-6, and IL-8) and significant increase for anabolic and anti-inflammatory molecules (IGF-1 and IL-10).
We conclude that intra-articular SVF infiltration for knee OA treatment is safe and effective during 1 year. We propose that applied SVF cells cause a cascade of molecular and structural events that, through complex interactions between IFP and SVF, re-educating the intra-articular fatty tissue towards a homeostatic, protective, and anti-inflammatory function, which will ultimately promote the restructuring and regeneration of damaged tissues.
自体脂肪组织基质血管成分(SVF)的渗透已用于治疗骨关节炎多年,其安全性和显著疗效已得到证实。本文介绍了中重度膝关节骨关节炎患者的临床数据,这些患者接受了膝关节内注射这种自体细胞产品的治疗,术后 1 年进行了评估,结果显示了该治疗方法的安全性和临床疗效。然而,我们对这种临床改善的机制了解多少呢?本文首次提出了一个假说,认为 SVF 与髌下脂肪垫(IFP)之间的结构和分子相互作用是其作用机制。因此,会有一个关节内脂肪组织的再教育,我们认为这是观察到的中远期临床效果的关键因素,主要是由于免疫调节机制。
这是一项回顾性非对照研究,评估了 50 名(100 个关节)年龄在 50 至 89 岁之间的患者,按年龄分组。使用 Lequesne、WOMAC 和 VAS 量表、超声检查和滑液生化特征的定量评估来评估临床疗效。
没有严重的不良事件。所有研究指标在所有年龄组和 OA 程度组的 1 年随访后均显示出显著的临床改善。这一发现与超声观察和生化数据相关,这些数据显示,分解代谢和促炎分子(MMP-2、IL-1B、IL-6 和 IL-8)显著减少,而合成代谢和抗炎分子(IGF-1 和 IL-10)显著增加。
我们得出结论,关节内 SVF 渗透治疗膝骨关节炎在 1 年内是安全有效的。我们提出,应用的 SVF 细胞会引起一系列分子和结构事件,通过 IFP 和 SVF 之间的复杂相互作用,使关节内脂肪组织重新向稳态、保护和抗炎功能发展,最终促进受损组织的重构和再生。